FDA Device Intelligence
Home › HORIBA INSTRUMENTS INCORPORATED › Pointe Propoxyphene (PPX) Reagent Set

Pointe Propoxyphene (PPX) Reagent Set

HORIBA INSTRUMENTS INCORPORATED · Model 60-PP0240-100 · UDI-DI 00811727017918

JXN Prescription
1
510(k) clearances
1
Adverse events
2
Recalls
55
Facilities

Description

Pointe Propoxyphene (PPX) Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Propoxyphene (PPX) Reagent Set is intended for the qualitative and semi-quantitative determination of propoxyphene in human urine at a cutoff value of 300 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.

Recalls

DateFirmReason
2010-10-04Express Diagnostics Int'l., Inc.Express Diagnostics Int'l, Inc (EDI), is recalling DrugCheck Drug Screen Cups containing buprenorphine (BUP) and propoxyphene (PPX) because they must be labeled as "forensic use o
2008-05-28Sun Biomedical Laboratories, Inc.Product was sold while the devices were under FDA 510 (k) review, which was subsequently denied.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.